Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 212 results
  • Sort by
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location

Study of 225Ac-PSMA-617 in Men With PSMA-positive Prostate Cancer

 		Prostatic Neoplasms, Castration-Resistant Phase 1 Australia
South Africa

Study to Compare the Pharmacokinetics of Fixed-Dose Combination of Mometasone + Azelastine Nasal Spray to Mometasone and Azelastine Nasal Sprays in Adolescents and Young Adults With Seasonal Allergic Rhinitis

 		Seasonal Allergic Rhinitis Phase 1 Canada

Observational Study, to Assess Treatment Retention of an Adalimumab Biosimilar (Hyrimoz®) in IBD Patients in Real Life Setting

 		Inflammatory Bowel Disease France

Study to Evaluate Safety and Dosimetry of Lutathera in Adolescent Patients With GEP-NETs and PPGLs

 		Gastroenteropancreatic Neuroendocrine Tumors, Pheochromocytoma, Paraganglioma Phase 2 Italy
France
United States
Canada
Spain
Poland
Netherlands
United Kingdom
Belgium
View All

Post-Authorization Safety Study (PASS) of LysaKare® in Adult Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients

 		Gastroenteropancreatic Neuroendocrine Tumors Phase 4 Netherlands
Poland
Italy
United Kingdom
View All

[177Lu]-NeoB in Patients With Advanced Solid Tumors and With [68Ga]-NeoB Lesion Uptake

 		Neoplasms Phase 1, Phase 2 United Kingdom
United States
Netherlands
Austria
Spain
View All

Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)

 		Spinal Muscular Atrophy (SMA) United States
Russian Federation
Japan
Portugal
Ireland
Greece
Taiwan
Korea, Republic of
Israel
View All

Characterizing Guideline Adoption and Treatment Quality in Clinical Routine of German HFrEF Care

 		Heart Failure Germany

Special Drug Use Surveillance of Entresto Tablets (Hypertension)

 		Hypertension Japan

Asciminib RMP Study

 		Chronic Myeloid Leukemia Korea, Republic of